Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the coronavirus (Covid-19) outbreak on our timeline

Jack Ma Foundation has awarded a $2.1m grant to four research teams at Columbia University to identify antiviral drugs and antibodies that can be used against the Covid-19 coronavirus.

The grant will be split between the four teams, which will partner with academic researchers in China trying to control the spread of the coronavirus epidemic.

Teams from Columbia will explore four different methods to develop drugs and antibodies that can stop viral replication.

Each of the different approaches will be based on previous knowledge from the successes of antiviral therapies formulated against HIV and hepatitis C.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Columbia teams will pursue projects aimed at identifying or developing two types of antiviral drugs and one type of virus-neutralizing antibody

The teams will aim to develop one type of virus-neutralizing antibody and two types of antiviral drugs.